Clinical Trial Update: Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating the combination of trametinib and hydroxychloroquine for pancreatic cancer; the study is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Trametinib (trametinib)

Snippet

Sponsor: University of Utah | Conditions: Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING